158
Views
2
CrossRef citations to date
0
Altmetric
Urogenital Radiology

Contrast medium nephrotoxicity after renal artery and coronary angioplasty

, , , , , , , & show all
Pages 462-466 | Accepted 07 Jan 2010, Published online: 02 Mar 2010

References

  • Andrew E, Berg KJ. Nephrotoxic effects of X-ray contrast media. J Toxicol Clin Toxicol 2004;42:325–32.
  • Porter GA. Contrast associated nephropathy. Am J Cardiol 1989;649(9 Suppl):22E–26E.
  • Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, . The prognostic implication of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542–8.
  • McCullogh PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997;103:368–75.
  • Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491–6.
  • Briguori C, Tavano D, Colombo A. Contrast agent-associated nephotoxicity. Prog Cardiovasc Dis 2003;45–6:493–503.
  • Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years or older. Arch Intern Med 1995;150:1237–42.
  • Rudnik MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast-media associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis 1994;24:713–27.
  • Brezis M, Rosen S. Hypoxia of the renal medulla - its complication for disease. N Engl J Med 1995;332:647–55.
  • Muray S, Martin M, Amodeo ML, García C, Jornet AR, Vera M, . Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 2002;39:60–6.
  • Safian RD, Textor SC. Medical progress: renal-artery stenosis. N Engl J Med 2001;344:431–42.
  • Bakker J, Goffette PP, Henry M, Mali WP, Melki JP, Moss JG, . The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999;22:468–74.
  • Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999;92:159–67.
  • Lederman RJ, Mendelsohn FO, Santos R., Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314–23.
  • Zeller T, Frank U, Muller C, Bürgelin K, Sinn L, Horn B, . Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long term results from a prospective registry of 456 lesions. J Endovasc Ther 2004;11:95–106.
  • Tsao CR, Wen-Lieng L, Tsun-Jui L, Chen YT, Ting CT. Delicate percutaneous renal artery stenting minimizes postoperative renal injury and protects kidney in patients with severe athrosclerotic renal artery stenosis and imparired renal function. Int Heart J 2005;46:1061–72.
  • Potus B, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14–22.
  • Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003;76:513–18.
  • Rudnick M, Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med 2003;4(Suppl 5):S28–S33.
  • Mehran R, Ashby D. Radiocontrast-induced acute renal failure: allocations and outcomes. Rev Cardiovasc Med 2001;2(Suppl 1):S9–S13.
  • Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3–9.
  • Lufft V, Hoogestraat-Lufft L, Fels LM, Egbeyong-Baiyee D, Olbricht CJ, Galanski M. Angiography for renal artery stenosis: no additional impairment of renal function by angioplasty. Eur Radiol 2002;12:804–9.
  • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–S119.
  • Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, . Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003;41:47–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.